Selected Publications

Michniacki, T, Warren, JT: Supportive Care for Chronic Neutropenia. Hematology American Society of Hematology Education Program (ASH Education); Companion Presentation at ASH Annual Meeting December 2026 December 2026.

Clark, ME, Baldino, S, Zelley, K, MacFarland, SP, Tasian, SK, Warren, JT, Luo, M, Li, MM, Newman, H: Practice Change in Genetic Evaluation for Pediatric Patients with Acute Myeloid Leukemia. FASEB SRC Genetic Basis of Blood Cancers and Bone Marrow Failure, Niagra Falls, NY; Poster August 2026.

Yen, D, Tober, J, Zezulin, A, Bresciani, E, Kajdic, A, Tan, K, Liu, P, Gollomp, K, Warren, JT, Yu, W, Speck, N: Characteristics of granulopoiesis in RUNX1 familial platelet disorder. FASEB SRC Genetic Basis of Blood Cancers and Bone Marrow Failure, Niagra Falls, NY; oral presentation August 2026.

Mohan, S, Carlelycke, TE, Koppayi, AL, Walker, T, Tallis, E, Trottier, AM, Calvo, KR, Marciano, BE, Hsu, AP, Holland, SM, Hickstein, DD, Wlodarski, MW, Kozyra, E, Collin, M, Hahn, CN, Brown, AL, Blombery, P, Tiong, IS, Kankanige, Y, Fox, LC, Keel, SB, Horwitz, MS, Vulliamy, TJ, Dokal, I, Mendes-de-Almeida, DP, Calado, RT, Cavalcante de Andrade Silva, M, Elvira Deolinda Rodrigues Pereira Velloso, DiNardo, CD, Izraeli, S, Yacobovich, J, Sherbeck, M, Warren, JT, Luo, M, Smith, WJ, Hattig, Z, Stubbins, RJ, Feurstein, SK, Baliakas, P, Luo, X, Martin, AR, Gordon, A, Bresnick, EH, Gao, G, Kocherginsky, M, Wu, D, Godley, LA: A quantitative definition of the clinical manifestations of GATA2 deficiency in adults. Blood August 2026.

Vido, MJ, Bautista, G, Warren, JT: Mitochondrial proteostatic stress contributes to dysregulated granulopoiesis. FASEB SRC Genetic Basis of Blood Cancers and Bone Marrow Failure, Niagra Falls, NY; oral presentation August 2026.

Luo, M, Warren, JT, Teferedegn, E, Fanning, EA, Denenberg, EH, Luke,T, Charles,S, Moseley, AD, Wu, J, Schubert, J, Lea, S, Zhong, Y, Lambert, M, Paessler, M, Kurre, P, Olson, TS, Li, MM: Evaluating Genetic Testing Approaches in Bone Marrow Failure: Insights from Diagnostic Yield Across Multiple Assays. Cancer Genomics Consortium Annual Meeting, Houston, TX, Poster August 2026.

Warren, JT, Dickerson, KE, Sharathkumar, A, Walter, JE, Wilson, DB, Adell, K, Dubuc, S, Li, X, Wilson, S, Wu, H, Arbet-Engels, C, Steiner, DJ: “Evaluating the Safety and Efficacy of Mavorixafor, an Oral CXCR4 Antagonist, in Participants with Primary Chronic Neutropenic Disorders: Results from the Phase 2 Study." HemaSphere 9(S1), June 2025.

Newman, H, Clark, ME, Wong, D, Wu, J, Brodeur, GM, Hunger, SP, Tasian, SK, Olson, TS, Warren, JT, Teachey, DT, Schubert, J, Golenberg, N, Patel, M, Denenberg, EH, Fanning, EA, Chen, J, Luke, T, Charles, S, Gallo, D, Cao, K, Fu, W, Fan, Z, Surrey, LF, Wertheim, G, Luo, M, MacFarland, SP, Li, MM, Zhong, Y. : "Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: Tumor-only versus paired tumor-normal sequencing." Haematologica 109(9): 3024-3030, Feb 2024.

Oved, JS, Gibson, NM, Vanella, K, Elgarten, CW, Wray, L, Warren, JT, Olson, TS.: "Reduced Toxicity Matched Sibling Bone Marrow Transplant Results in Excellent Outcomes for Severe Congenital Neutropenia." Frontiers in Immunology 15(1): 1369243, Feb 2024.

Warren, JT, Dickerson, KE, Sharathkumar, AA, Walter, JE, Wilson, DB, Adell, KP, Chen, K, Dubuc, S, MacLeod, R, Peters, K, Steward, M, Taveras, AG, Walkovich, K. : “Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, Open-Label, Multicenter Study Support Reduction in G-CSF Dosing.” American Society of Hematology Annual Meeting, San Diego, CA, Poster Dec 2023.